AL

Alixia

YC W22

San Francisco, US · Founded 2022 · 2 employees · 1 known investors

alixia.com ↗

Alixia develops therapeutics targeting tumor ecosystems to address cancer drug resistance and age-related diseases. The company integrates biology, biophysics, and computational chemistry to design compounds that disrupt metabolic and inflammatory triggers in multiple cell types within the tumor microenvironment.

Founders & leadership· Y Combinator alumni (W22)

Olof MollstedtinFounder

Helen CheninFounder

Investors · 1

Y

Y CombinatorMountain View · $500K – $500K